facebook
twitter
search
search

Aspirin, ibuprofen may lower melanoma risk

May 29, 2012 at 8:04 PM

AARHUS, Denmark, May 29 (UPI) -- Danish researchers said people who took non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen lowered their risk of melanoma.

Sigrun Alba Johannesdottir of Aarhus University Hospital in Denmark and colleagues conducted a case-control study from prescription-drug registries involving almost 2 million people living in northern Denmark, MedPage Today reported.

The researchers identified all residents who had at least a two-year prescription history from 1989 to 2008.

NSAID users were defined as residents who filled more than two prescriptions for NSAIDs or aspirin during the study period. Short-term NSAID use was defined as less than seven years, and long-term use as seven years or longer. Anyone who filled two or fewer prescriptions was identified as a non-user.

Cases of skin cancer were ascertained by data from the Danish national cancer registry the researchers identified 1,974 patients who developed squamous-cell skin cancer, 13,316 who developed basal-cell skin cancer and 3,242 who had a history of melanoma.

The study, published online ahead of the print issue of the journal Cancer, found the combination of high-intensity use over a long duration reduced melanoma risk by 46 percent, while high-intensity use for a long duration reduced squamous-cell skin cancer risk by 35 percent and basal-cell skin cancer risk by 17 percent.

Like Us on Facebook for more stories from UPI.com  
Latest Headlines
Top Stories
Elastic gel stops bleeding, helps wounds heal
FDA to look at risks of treating children with codeine
Device helps doctors personalize chemotherapy for patients